HK1078802A1 - Increasing the bioavailability of alendronate by predose administration alphacalcidol - Google Patents

Increasing the bioavailability of alendronate by predose administration alphacalcidol

Info

Publication number
HK1078802A1
HK1078802A1 HK06101577.3A HK06101577A HK1078802A1 HK 1078802 A1 HK1078802 A1 HK 1078802A1 HK 06101577 A HK06101577 A HK 06101577A HK 1078802 A1 HK1078802 A1 HK 1078802A1
Authority
HK
Hong Kong
Prior art keywords
alphacalcidol
alendronate
bioavailability
increasing
predose
Prior art date
Application number
HK06101577.3A
Inventor
Vered Rosenberger
Moshe Flashner-Barak
Itzhak E Lerner
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HK1078802A1 publication Critical patent/HK1078802A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
HK06101577.3A 2002-12-16 2006-02-06 Increasing the bioavailability of alendronate by predose administration alphacalcidol HK1078802A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43368502P 2002-12-16 2002-12-16
US46020603P 2003-04-02 2003-04-02
PCT/US2003/040174 WO2004058235A2 (en) 2002-12-16 2003-12-16 Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative

Publications (1)

Publication Number Publication Date
HK1078802A1 true HK1078802A1 (en) 2006-03-24

Family

ID=32685268

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06101577.3A HK1078802A1 (en) 2002-12-16 2006-02-06 Increasing the bioavailability of alendronate by predose administration alphacalcidol

Country Status (7)

Country Link
JP (3) JP2006514695A (en)
AU (1) AU2003300984A1 (en)
DE (1) DE10393906T5 (en)
GB (1) GB2411116B (en)
HK (1) HK1078802A1 (en)
IL (1) IL169127A0 (en)
WO (1) WO2004058235A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2882048C (en) * 2006-02-03 2020-03-24 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
CN101404982A (en) * 2006-02-14 2009-04-08 特瓦制药工业有限公司 Pharmaceutical formulation of aliphatic amine polymer and their preparation method
ES2497494T3 (en) 2006-06-21 2014-09-23 Opko Renal, Llc Method of treatment and prevention of secondary hyperparathyroidism
CA2671727C (en) * 2006-12-20 2016-02-16 Genpharm Ulc A composition containing a bisphosphonic acid in combination with vitamin d
JP5290198B2 (en) * 2006-12-20 2013-09-18 ミラン ファーマシューティカルズ ユーエルシー Pharmaceutical composition comprising hot melt granulated lubricant
WO2008134523A1 (en) 2007-04-25 2008-11-06 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
WO2009047644A2 (en) 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
KR20190028822A (en) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 Oral controlled release compositions comprising vitamin d compound and waxy carrier
WO2008134518A2 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
US8962239B2 (en) 2008-04-02 2015-02-24 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
PT2552484T (en) 2010-03-29 2020-04-03 Opko Ireland Global Holdings Ltd Methods and compositions for reducing parathyroid levels
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
EP3193925A2 (en) 2014-08-07 2017-07-26 OPKO Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin d
IL290855B1 (en) 2016-03-28 2024-02-01 Eirgen Pharma Ltd Methods of vitamin d treatment
CN109364034B (en) * 2018-11-26 2021-05-04 正大制药（青岛）有限公司 Calcitriol preparation and preparation method thereof
CN116211818B (en) * 2023-03-10 2024-04-09 菲洋生物科技(吉林)有限公司 Tablet containing alendronate sodium and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317935B1 (en) * 1999-10-20 2001-12-22 유승필 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
US20030158154A1 (en) * 2001-07-17 2003-08-21 Moshe Fleshner-Barak Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate

Also Published As

Publication number Publication date
JP2011241221A (en) 2011-12-01
AU2003300984A8 (en) 2004-07-22
WO2004058235A3 (en) 2005-02-24
JP2006514695A (en) 2006-05-11
JP2014205711A (en) 2014-10-30
IL169127A0 (en) 2009-02-11
GB2411116A (en) 2005-08-24
DE10393906T5 (en) 2006-01-12
GB0511750D0 (en) 2005-07-20
AU2003300984A1 (en) 2004-07-22
GB2411116B (en) 2009-04-29
WO2004058235A2 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
HK1078802A1 (en) Increasing the bioavailability of alendronate by predose administration alphacalcidol
GB0218625D0 (en) Pharmaceutical compounds
GB0217225D0 (en) Medicinal compounds
GB0225540D0 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
GB0220730D0 (en) Medicinal compounds
GB0225030D0 (en) Medicinal compounds
GB0215775D0 (en) Pharmaceutical compounds
HK1075936A1 (en) Vaccine for the prevention of malaria
EP1617847A4 (en) Methods for the controlled delivery of pharmacologically active compounds
GB0220740D0 (en) Administration of a system
ITRM20050030A1 (en) PROCEDURE FOR THE SYNCHRONIZED ACTIVATION OF A PLURALITY OF ELECTRONIC CAMERAS.
GB0204392D0 (en) Pharmaceutical compound
GB0328040D0 (en) Pharmaceutical uses of bisphosphonates
GB0310361D0 (en) Pharmaceutical compound
GB0219897D0 (en) Pharmaceutically active compounds
GB0219893D0 (en) Pharmaceutically active compounds
ZA200204577B (en) Formulations of erytromycin derivatives with improved bioavailability.
GB0424063D0 (en) Administration system
GB0212462D0 (en) Pharmaceutical compound
GB0212459D0 (en) Pharmaceutical compound
GB0204391D0 (en) Pharmaceutical compound
GB0219895D0 (en) Pharmaceutically active compounds
GB0207532D0 (en) A novel method for the administration of secretin
GB0215939D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151216